Abstract:
Disclosed are embodiments of a laparoscopic access port having a head (portion 450) for use generally externally of a patient and for providing a seal around a laparoscopic tool (not shown)when said tool is inserted into the head via a (bore 408); and a sleeve portion (410) connected to the head and for accommodating the tool, the sleeve (410) extending along an axis and being adapted for inserting generally into the body of a patient in the direction of the axis;said access port being adjustable in overall length X in the direction of the axis, the sleeve portion comprising a shank (411) attached or attachable to the head (450) and a flanged piece (413) moveable relative to the shank by means of a mechanism for causing the overall length X of the port to adjust, the mechanism being operable externally of the patient at or adjacent the head, for example by means of rotation of an element of a lower head part (440), or by sliding motion of the shank (411) and flanged piece (413).
Abstract:
Disclosed are ruthenium complexes of phosphine-aminophosphine ligands that may be used to catalyze large number of reactions of a wide variety of substrates such as asymmetric hydrogenations, asymmetric reductions, asymmetric hydroborations, asymmetric olefin isomerizations, asymmetric hydrosilations, asymmetric allylations, and asymmetric organometallic additions. Also disclosed is a process for the preparation of the ruthenium complexes and processes for the enantioselective asymmetric hydrogenations of 1,3-dicarbonyl, α-hydroxycarbonyl, and β-hydroxycarbonyl compounds to produce the corresponding hydroxycarbonyl, 1,2-diol, and 1,3-diol compounds, respectively, using the ruthenium complexes to catalyze the hydrogenation.
Abstract:
Disclosed are processes for the preparation of enantiomerically-enriched cyclopropylalanine derivatives by the hydrogenation of certain enamides in the presence of a catalyst comprising a transition metal and a substantially enantiomerically-pure bis-phosphine catalyst and certain novel enamide ester compounds which are intermediates in the processes. The processes include novel 2-step and 3-step processes for the preparation of enantiomerically-enriched cyclopropylalanine derivatives. The two-step process comprises the steps of reacting cyclopropanecarboxaldehyde with a substituted phosphorylglycine to afford an enamide ester which then is hydrogenated in the presence of a catalyst comprising a transition metal and a substantially enantiomerically-pure bis-phosphine catalyst. The three-step process comprises the steps of forming an azlactone from an N-acylglycine and cyclopropanecarboxaldehyde, converting the azlactone to the aforesaid enamide which then is hydrogenated in the presence of a catalyst comprising a transition metal and a substantially enantiomerically-pure bis-phosphine catalyst.
Abstract:
Novel 2-substituted saccharins which inhibit the enzymatic activity of proteolytic enzymes, are useful in the treatment of degenerative diseases and have the formula ##STR1## wherein: L is --O--, --S--, --SO-- or --SO.sub.2 --;m and n are each independently 0 or 1;R.sub.1 is halo, lower-alkanoyl, 1-oxophenalenyl, phenyl or substituted phenyl, heterocyclyl or substitued heterocyclyl or, when L is --O-- and n is 1, cycloheptatrienon-2-yl or, whenL is --S-- and n is 1, cyano or lower-alkoxythiocarbonyl or, when L is --SO.sub.2 -- and n is 1, lower-alkyl or trifluoromethyl;R.sub.2 is hydrogen, lower-alkoxycarbonyl, phenyl or phenylthio; andR.sub.3 and R.sub.4 are each hydrogen or various substituents and processes for preparation and pharmaceutical compositions and method of use thereof are disclosed.
Abstract:
Carbonates of anti-aging ingredients, in particular anti-oxidants and skin illuminating phenol ingredients, have been prepared as derivatives of these ingredients with enhanced physical properties. It has been demonstrated that these carbonates will hydrolyze under enzymatic catalysis to release the parent ingredient. In contrast, esters of the phenolic groups in many cases do not hydrolyze under the same conditions.
Abstract:
Retinyl hydroxyesters and retinyl oligo-hydroxyesters were prepared using a chemoenzymatic process from retinol and short chain esters of hydroxycarboxylic acids or short chain esters of hydroxycarboxylic acids. The presence of the hydroxyl group on the acid can result in a mixture of esters from various oligomers of the hydroxycarboxylic acid. The retinyl ester products are readily enzymatically hydrolyzed in vitro, which indicates that application to the skin should result in release of the anti-aging ingredient retinol (without the inherent instability and irritation) along with the acid, which, if chosen appropriately, should also have desirable biological effects. This combination should be effective as an anti-aging skin care ingredient.
Abstract:
Disclosed is apparatus 100 for the reduction or removal of smoke particles suspended in a local atmosphere A and resulting from a surgical procedure, the apparatus including or comprising two electrodes 140 and 150 each in electrical communication with or being electrically connectable to opposite poles of a source of high voltage dc electricity. A first of the electrodes 140 may be electrically connectable to a patient P. and a second 150 may be positionable within or adjacent a patient such that the two electrodes, when in communication with opposite poles of said high voltage, ionise said particles in use, for attracting said particles toward the patient or toward the second of the electrodes.
Abstract:
Esters of O-substituted hydroxy carboxylic acids are provided having Formula 1, or 2, or both Formulas 1 and 2: wherein R and R1 are independently selected from the group consisting of substituted and unsubstituted, branched- and straight-chain, saturated, unsaturated, and polyunsaturated C1-C22 alkyl, substituted and unsubstituted C3-C8 cycloalkyl, substituted and unsubstituted C6-C20 carbocyclic aryl, and substituted and unsubstituted C4-C20 heterocyclic; wherein the heteroatoms are selected from sulfur, nitrogen, and oxygen; and wherein n is 1-6. Process of producing esters of O-substituted hydroxy carboxylic acids are also provided.
Abstract:
Surgical Manipulator A surgical manipulator (10) is disclosed which employs a suction cup (30) to hold body parts (50) whilst the manipulator is moved to manipulate the body part (50). Suction at the cup (30) is provided by means of a central passage (16) running through an extension (20) and through a handle part (14) to a vacuum connector (12). The suction at the cup (30) can be adjusted by a slider (15) which adjustably opens the passage (16) to atmosphere. Needles (58) and the like can be introduced into the passage (16) and thereby into the body part (50). For laparoscopic surgery the manipulator can be introduced into a laparoscopic port (52) by collapsing the suction cup (30) within an introducer sleeve (22 FIG. 3). The introducer sleeve (22) can act as a suction device when the cup (30) is collapsed within it. The needle (58) can be replaced by a diathermy electrode (60 FIG. 6) and irrigation is possible using an additional supply tube (121 FIG. 4).
Abstract:
Disclosed is a composition and methods of treating a skin condition. The ester includes an ester and a dermatologically acceptable carrier. The ester is represented by the general formula 1: